Search research articles
Contact Us
Filters
Showing results (81-90 of 132) with videos related to
Page
of 14
Sort By:
Cancer Letters
|
May 20, 2024
Personalized prediction of postoperative complication and survival among Colorectal Liver Metastases Patients Receiving Simultaneous Resection using machine learning approaches: A multi-center study
Qichen Chen, Jinghua Chen, Yiqiao Deng, et al.
Oncology Letters
|
March 20, 2023
Prognostic significance of the preoperative alkaline phosphatase‑to‑albumin ratio in patients with hepatocellular carcinoma after hepatic resection
Yikai Wang, Xinyu Bi, Hong Zhao, et al.
BMC Cancer
|
July 2, 2025
Preoperative circulating tumor cells indicate microvascular invasion and dynamical detection indicate the early recurrence of hepatocellular carcinoma
Xiaozhun Huang, Haoxiang Wen, Yan Huang, et al.
Translational Cancer Research
|
February 4, 2022
Differences of intraoperative outcomes and postoperative complications between intrahepatic cholangiocarcinoma and colorectal liver metastasis in different surgical methods
Qichen Chen, Yiling Zheng, Jinghua Chen, et al.
BMC Cancer
|
March 21, 2024
Tumor burden score and carcinoembryonic antigen predict outcomes in patients with intrahepatic cholangiocarcinoma following liver resection: a multi‑institutional analysis
Jun Fu, Lifang Zheng, Shicuan Tang, et al.
Human Molecular Genetics
|
December 6, 2012
Evidence of associations of APOBEC3B gene deletion with susceptibility to persistent HBV infection and hepatocellular carcinoma
Tongwen Zhang, Jianqiang Cai, Jiang Chang, et al.
Journal of Proteome Research
|
July 24, 2008
Quantitative proteomic signature of liver cancer cells: tissue transglutaminase 2 could be a novel protein candidate of human hepatocellular carcinoma
Yulin Sun, Wei Mi, Jianqiang Cai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 11, 2022
Serum Concentration of CD137 and Tumor Infiltration by M1 Macrophages Predict the Response to Sintilimab plus Bevacizumab Biosimilar in Advanced Hepatocellular Carcinoma Patients
Wen Zhang, Caifeng Gong, Xuenan Peng, et al.
Liver Research
|
February 17, 2025
Chinese expert consensus on refined diagnosis, treatment, and management of advanced primary liver cancer (2023 edition)
Xiufeng Liu, Feng Xia, Yue Chen, et al.
Journal for Immunotherapy of Cancer
|
January 29, 2026
PD-L1 expression on circulating tumor cells for predicting clinical outcomes in patients with hepatocellular carcinoma receiving PD-(L)1 blockade and targeted therapy
Caifeng Gong, Shuhui You, Qi Zhang, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 132) with videos related to
Sort By:
Page
of 14
Cancer Letters
|
May 20, 2024
Personalized prediction of postoperative complication and survival among Colorectal Liver Metastases Patients Receiving Simultaneous Resection using machine learning approaches: A multi-center study
Qichen Chen, Jinghua Chen, Yiqiao Deng, et al.
Oncology Letters
|
March 20, 2023
Prognostic significance of the preoperative alkaline phosphatase‑to‑albumin ratio in patients with hepatocellular carcinoma after hepatic resection
Yikai Wang, Xinyu Bi, Hong Zhao, et al.
BMC Cancer
|
July 2, 2025
Preoperative circulating tumor cells indicate microvascular invasion and dynamical detection indicate the early recurrence of hepatocellular carcinoma
Xiaozhun Huang, Haoxiang Wen, Yan Huang, et al.
Translational Cancer Research
|
February 4, 2022
Differences of intraoperative outcomes and postoperative complications between intrahepatic cholangiocarcinoma and colorectal liver metastasis in different surgical methods
Qichen Chen, Yiling Zheng, Jinghua Chen, et al.
BMC Cancer
|
March 21, 2024
Tumor burden score and carcinoembryonic antigen predict outcomes in patients with intrahepatic cholangiocarcinoma following liver resection: a multi‑institutional analysis
Jun Fu, Lifang Zheng, Shicuan Tang, et al.
Human Molecular Genetics
|
December 6, 2012
Evidence of associations of APOBEC3B gene deletion with susceptibility to persistent HBV infection and hepatocellular carcinoma
Tongwen Zhang, Jianqiang Cai, Jiang Chang, et al.
Journal of Proteome Research
|
July 24, 2008
Quantitative proteomic signature of liver cancer cells: tissue transglutaminase 2 could be a novel protein candidate of human hepatocellular carcinoma
Yulin Sun, Wei Mi, Jianqiang Cai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 11, 2022
Serum Concentration of CD137 and Tumor Infiltration by M1 Macrophages Predict the Response to Sintilimab plus Bevacizumab Biosimilar in Advanced Hepatocellular Carcinoma Patients
Wen Zhang, Caifeng Gong, Xuenan Peng, et al.
Liver Research
|
February 17, 2025
Chinese expert consensus on refined diagnosis, treatment, and management of advanced primary liver cancer (2023 edition)
Xiufeng Liu, Feng Xia, Yue Chen, et al.
Journal for Immunotherapy of Cancer
|
January 29, 2026
PD-L1 expression on circulating tumor cells for predicting clinical outcomes in patients with hepatocellular carcinoma receiving PD-(L)1 blockade and targeted therapy
Caifeng Gong, Shuhui You, Qi Zhang, et al.
Page
of 14